D. I. Jones

Suggest Changes
Learn More
INTRODUCTION Glycoprotein IIb/IIIa inhibitors are recommended by guidelines in patients with ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention. There(More)
  • 1